Artificial intelligence in COVID-19 drug repurposing

Deep learning

LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126 · see citing works

Learning representations by back-propagating errors

Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892 · see citing works

The central role of the propensity score in observational studies for causal effects

ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Dexamethasone in Hospitalized Patients with Covid-19

The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477 · see citing works

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · see citing works

I.—COMPUTING MACHINERY AND INTELLIGENCE

TURING, A. M. (1950) · Mind · doi:10.1093/mind/lix.236.433 · Cited by 10,290 · see citing works

Remdesivir for the Treatment of Covid-19 — Final Report

Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267 · see citing works

Computing Machinery and Intelligence (1950)

Turing, A. M. (2004) · doi:10.1093/oso/9780198250791.003.0017 · Cited by 6,120 · see citing works

Untitled work

(2013) · Cited by 5,726 · see citing works

LINE: Large-scale Information Network Embedding

Tang, J., Qu, M., Wang, M., Zhang, M., Yan, J., & Mei, Q. (2015) · Proceedings of the 24th International Conference on World Wide Web · doi:10.1145/2736277.2741093 · Cited by 5,416 · see citing works

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405 · see citing works

The trinity of COVID-19: immunity, inflammation and intervention

Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360 · see citing works

Extrapulmonary manifestations of COVID-19

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185 · see citing works

Proceedings of the 23rd international conference on Machine learning

Cohen, W. W., & Moore, A. (2006) · Cited by 2,647 · see citing works

Convolutional 2D Knowledge Graph Embeddings

Dettmers, T., Minervini, P., Stenetorp, P., & Riedel, S. (2018) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v32i1.11573 · Cited by 2,486 · see citing works

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,357 · see citing works

Real-World Evidence — What Is It and What Can It Tell Us?

Sherman, R. E., Anderson, S. A., Pan, G. J. D., Gray, G. W., Gross, T. P., Hunter, N. L., LaVange, L. M., Marinac‐Dabic, D., Marks, P. W., Robb, M. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmsb1609216 · Cited by 2,134 · see citing works

Complex Embeddings for Simple Link Prediction

Trouillon, T., Welbl, J., Riedel, S., Gaussier, É., & Bouchard, G. (2016) · arXiv · doi:10.48550/arxiv.1606.06357 · Cited by 2,100 · see citing works

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hú, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070 · see citing works

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

The Severe Covid-19 GWAS Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2020283 · Cited by 1,986 · see citing works

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852 · see citing works

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,588 · see citing works

Federated Learning for Healthcare Informatics

Xu, J., Glicksberg, B. S., Su, C., Walker, P., Bian, J., & Wang, F. (2021) · Journal of Healthcare Informatics Research · doi:10.1007/s41666-020-00082-4 · Cited by 1,542 · see citing works

Federated Learning for Healthcare Informatics

Xu, J., Glicksberg, B. S., Su, C., Walker, P., Bian, J., & Wang, F. (2019) · arXiv · doi:10.48550/arxiv.1911.06270 · Cited by 1,538 · see citing works

Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks

Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537 · see citing works

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456 · see citing works

Remdesivir for the Treatment of Covid-19 — Preliminary Report

Gillenwater, S., Rahaghi, F., & Hadeh, A. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,422 · see citing works

RotatE: Knowledge Graph Embedding by Relational Rotation in Complex Space

Sun, Z., Deng, Z.-H., Nie, J.-Y., & Tang, J. (2019) · arXiv · doi:10.48550/arxiv.1902.10197 · Cited by 1,414 · see citing works

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015301 · Cited by 1,362 · see citing works

Definition, structure, content, use and impacts of electronic health records: A review of the research literature

Häyrinen, K., Saranto, K., & Nykänen, P. (2008) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2007.09.001 · Cited by 1,303 · see citing works

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., et al. (2020) · Science · doi:10.1126/science.abc1560 · Cited by 1,219 · see citing works

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Rosenberg, E. S., Dufort, E. M., Udo, T., Wilberschied, L. A., Kumar, J., Tesoriero, J. M., Weinberg, P., Kirkwood, J., Muse, A., DeHovitz, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.8630 · Cited by 1,162 · see citing works

Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers

George, H., Duke Jon, D., Shah Nigam, H., Reich Christian, G., Vojtech, H., Schuemie Martijn, J., Suchard Marc, A., Woong, P. R., Kei, W. I. C., Rijnbeek Peter, R., et al. (2015) · Studies in Health Technology and Informatics · doi:10.3233/978-1-61499-564-7-574 · Cited by 1,107 · see citing works

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

Mancia, G., Rea, F., Ludergnani, M., Apolone, G., & Corrao, G. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006923 · Cited by 1,071 · see citing works

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

Reynolds, H. R., Adhikari, S., Pulgarin, C., Troxel, A. B., Iturrate, E., Johnson, S. B., Hausvater, A., Newman, J. D., Berger, J. S., Bangalore, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008975 · Cited by 1,058 · see citing works

New uses for old drugs

Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 996 · see citing works

Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2)

Murphy, S. N., Weber, G. M., Mendis, M., Gainer, V. S., Chueh, H. C., Churchill, S. E., & Kohane, I. S. (2010) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2009.000893 · Cited by 926 · see citing works

Improving propensity score weighting using machine learning

Lee, B. K., Lessler, J., & Stuart, E. A. (2009) · Statistics in Medicine · doi:10.1002/sim.3782 · Cited by 888 · see citing works

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.025 · Cited by 815 · see citing works

Network-based prediction of drug combinations

Cheng, F., Kovács, I. A., & Barabási, A.-Ĺ. (2019) · Nature Communications · doi:10.1038/s41467-019-09186-x · Cited by 812 · see citing works

AtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug DiscoveryPreprint

Wallach, I., Dzamba, M., & Heifets, A. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1510.02855 · Cited by 698 · see citing works

Corticosteroids

Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692 · see citing works

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675 · see citing works

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 653 · see citing works

Launching PCORnet, a national patient-centered clinical research network

Fleurence, R., Curtis, L. H., Califf, R. M., Platt, R., Selby, J. V., & Brown, J. S. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002747 · Cited by 637 · see citing works

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond

Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2030 · Cited by 632 · see citing works

Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data

Aliper, A., Plis, S., Artemov, A., Ulloa, A., Mamoshina, P., & Zhavoronkov, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00248 · Cited by 610 · see citing works

Network-based approach to prediction and population-based validation of in silico drug repurposing

Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barabási, A.-L., & Loscalzo, J. (2018) · Nature Communications · doi:10.1038/s41467-018-05116-5 · Cited by 552 · see citing works

How artificial intelligence is changing drug discovery

Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546 · see citing works

Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

Hoffmann, M., Mösbauer, K., Hofmann-Winkler, H., Kaul, A., Kleine‐Weber, H., Krüger, N., Gassen, N. C., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020) · Nature · doi:10.1038/s41586-020-2575-3 · Cited by 476 · see citing works

Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

Stang, P. E., Ryan, P. B., Racoosin, J. A., Overhage, J. M., Hartzema, A. G., Reich, C., Welebob, E., Scarnecchia, T., & Woodcock, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00010 · Cited by 441 · see citing works

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis

Hou, Y., Zhao, J., Martin, W., Kallianpur, A. R., Chung, M. K., Jehi, L. E., Sharifi, N., ERZURUM, S. C., Eng, C., & Cheng, F. (2020) · BMC Medicine · doi:10.1186/s12916-020-01673-z · Cited by 438 · see citing works

Using deep learning to model the hierarchical structure and function of a cell

Ma, J., Yu, M. K., Fong, S., Ono, K., Sage, E., Demchak, B., Sharan, R., & Ideker, T. (2018) · Nature Methods · doi:10.1038/nmeth.4627 · Cited by 435 · see citing works

Target identification among known drugs by deep learning from heterogeneous networks

Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357 · see citing works

Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set

Lenselink, E. B., ten Dijke, N., Bongers, B., Papadatos, G., van Vlijmen, H. W. T., Kowalczyk, W., IJzerman, A. P., & van Westen, G. J. P. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0232-0 · Cited by 334 · see citing works

Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

Maisonnasse, P., Guedj, J., Contreras, V., Behillil, S., Solas, C., Marlin, R., Naninck, T., Pizzorno, A., Lemaître, J., Gonçalves, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2558-4 · Cited by 331 · see citing works

The $2.6 Billion Pill — Methodologic and Policy Considerations

Avorn, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500848 · Cited by 322 · see citing works

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00568-6 · Cited by 300 · see citing works

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Zeng, X., Song, X. H., Ma, T., Pan, X., Zhou, Y., Hou, Y., Zhang, Z., Li, K., Karypis, G., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00316 · Cited by 258 · see citing works

Interpretable Drug Target Prediction Using Deep Neural Representation

Gao, K. Y., Fokoue, A., Luo, H., Iyengar, A., Dey, S., & Zhang, P. (2018) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2018/468 · Cited by 248 · see citing works

Putting the Patient Back Together — Social Medicine, Network Medicine, and the Limits of Reductionism

Greene, J. A., & Loscalzo, J. (2017) · New England Journal of Medicine · doi:10.1056/nejmms1706744 · Cited by 206 · see citing works

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

Park, S.-J., Yu, K.-M., Kim, Y., Kim, S.-M., Kim, E.-H., Kim, S.-G., Kim, E. J., Casel, M. A. B., Rollon, R., Jang, S., et al. (2020) · mBio · doi:10.1128/mbio.01114-20 · Cited by 186 · see citing works

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180 · see citing works

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19Preprint

Ge, Y., Tian, T., Huang, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.11.986836 · Cited by 168 · see citing works

Visible Machine Learning for Biomedicine

Yu, M. K., Ma, J., Fisher, J., Kreisberg, J. F., Raphael, B. J., & Ideker, T. (2018) · Cell · doi:10.1016/j.cell.2018.05.056 · Cited by 162 · see citing works

AI-powered drug discovery captures pharma interest

Smalley, E. (2017) · Nature Biotechnology · doi:10.1038/nbt0717-604 · Cited by 152 · see citing works

Supervised patient similarity measure of heterogeneous patient records

Sun, J., Wang, F., Hu, J., & Edabollahi, S. (2012) · ACM SIGKDD Explorations Newsletter · doi:10.1145/2408736.2408740 · Cited by 149 · see citing works

Ethics and governance for digital disease surveillance

Mello, M. M., & Wang, C.-H. J. (2020) · Science · doi:10.1126/science.abb9045 · Cited by 147 · see citing works

Publisher Correction: Network-based prediction of drug combinations

Cheng, F., Kovács, I. A., & Barabási, A.-L. (2019) · Nature Communications · doi:10.1038/s41467-019-09692-y · Cited by 131 · see citing works

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers

Nussinov, R., Jang, H., Tsai, C., & Cheng, F. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006658 · Cited by 129 · see citing works

A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases

Sosa, D. N., Derry, A., Guo, M. G., Wei, E., Brinton, C., & Altman, R. B. (2019) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789811215636_0041 · Cited by 110 · see citing works

Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107 · see citing works

Randomized Clinical Trials and COVID-19

Bauchner, H., & Fontanarosa, P. (2020) · JAMA · doi:10.1001/jama.2020.8115 · Cited by 106 · see citing works

GraphVite: A High-Performance CPU-GPU Hybrid System for Node Embedding

Zhu, Z., Xu, S., Tang, J., & Qu, M. (2019) · International World Wide Web Conference (WWW) · doi:10.1145/3308558.3313508 · Cited by 104 · see citing works

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells

Cong, Y., Hart, B. J., Gross, R., Zhou, H., Frieman, M. B., Bollinger, L., Wada, J., Hensley, L. E., Jahrling, P. B., Dyall, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194868 · Cited by 98 · see citing works

Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing

Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 93 · see citing works

Learning Drug Functions from Chemical Structures with Convolutional Neural Networks and Random Forests

Meyer, J. G., Liu, S., Miller, I. J., Coon, J. J., & Gitter, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00236 · Cited by 91 · see citing works

Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV‑2

Martin, W. R., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00397 · Cited by 66 · see citing works

A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare DiseasesPreprint

Sosa, D. N., Derry, A., Guo, M. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/727925 · Cited by 61 · see citing works

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis

Cheng, F., Murray, J. L., Zhao, J., Sheng, J., Zhao, Z., & Rubin, D. H. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005074 · Cited by 58 · see citing works

Toremifene

Wiseman, L. R., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199754010-00014 · Cited by 55 · see citing works

Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis

Mehta, H. B., Ehrhardt, S., Moore, T. J., Segal, J. B., & Alexander, G. C. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039978 · Cited by 54 · see citing works

Healthcare in the Age of Interoperability: The Promise of Fast Healthcare Interoperability Resources

Braunstein, M. L. (2018) · IEEE Pulse · doi:10.1109/mpul.2018.2869317 · Cited by 53 · see citing works

Combining machine learning and propensity score weighting to estimate causal effects in multivalued treatments

Linden, A., & Yarnold, P. R. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12610 · Cited by 31 · see citing works

Convolutional 2D Knowledge Graph Embeddings

Dettmers, T., Minervini, P., Stenetorp, P., & Riedel, S. (2017) · arXiv · doi:10.48550/arxiv.1707.01476 · Cited by 30 · see citing works

COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach

Cheng, F., Rao, S., & Mehra, R. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc037 · Cited by 26 · see citing works

Thalidomide maintenance in multiple myeloma

Laubach, J. P., Richardson, P. G. G., & Anderson, K. C. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.131 · Cited by 12 · see citing works

The role of AI in drug discovery: challenges, opportunities, and strategies

Blanco-González, A., Cabezón, A., Seco-González, A., Conde-Torres, D., Antelo-Riveiro, P., Piñeiro, Á., & Garcia-Fandino, R. (2023) · Pharmaceuticals · doi:10.3390/ph16060891 · Cited by 690 · see citing works

The Ethics of Artificial Intelligence

Floridi, L. (2023) · doi:10.1093/oso/9780198883098.001.0001 · Cited by 608 · see citing works

Artificial intelligence in drug development

Zhang, K., Yang, X., Wang, Y., Yu, Y., Huang, N., Li, G. L., Li, X., Wu, J. C., & Yang, S. (2025) · Nature Medicine · doi:10.1038/s41591-024-03434-4 · Cited by 538 · see citing works

Building a knowledge graph to enable precision medicine

Chandak, P., Huang, K., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01960-3 · Cited by 522 · see citing works

Artificial intelligence in cancer target identification and drug discovery

You, Y., Lai, X., Pan, Y. F., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 476 · see citing works

Deep Learning applications for COVID-19

Shorten, C., Khoshgoftaar, T. M., & Furht, B. (2021) · Journal of Big Data · doi:10.1186/s40537-020-00392-9 · Cited by 350 · see citing works

Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework

Zeng, X., Xiang, H., Yu, L., Wang, J., Li, K., Nussinov, R., & Cheng, F. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00557-6 · Cited by 310 · see citing works

Deep generative molecular design reshapes drug discovery

Zeng, X., Wang, F., Luo, Y., Kang, S.-G., Tang, J., Lightstone, F. C., Fang, E. F., Cornell, W., Nussinov, R., & Cheng, F. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100794 · Cited by 295 · see citing works

Integrating Artificial Intelligence for Drug Discovery in the Context of Revolutionizing Drug Delivery

Vișan, A. I., & Neguț, I. (2024) · Life · doi:10.3390/life14020233 · Cited by 321 · see citing works

A definition, benchmark and database of AI for social good initiatives

Cowls, J., Tsamados, A., Taddeo, M., & Floridi, L. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00296-0 · Cited by 212 · see citing works

Drug repurposing for COVID-19 via knowledge graph completion

Zhang, R., Hristovski, D., Schutte, D., Kastrin, A., Marcelo Fiszman, B., & Halil Kilicoglu, B. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103696 · Cited by 224 · see citing works

Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review

Khan, M., Mehran, M. T., Haq, Z. U., Ullah, Z., Naqvi, S. R., Ihsan, M., & Abbas, H. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.115695 · Cited by 206 · see citing works

A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets

Zhou, Y., Liu, Y., Gupta, S., Paramo, M. I., Hou, Y., Mao, C., Luo, Y., Judd, J., Wierbowski, S. D., Bertolotti, M., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01474-0 · Cited by 203 · see citing works

AlphaFold, Artificial Intelligence (AI), and Allostery

Nussinov, R., Zhang, M., Liu, Y., & Jang, H. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c04346 · Cited by 190 · see citing works

Robotics and artificial intelligence in healthcare during COVID-19 pandemic: a systematic review

Sarker, S., Jamal, L., Ahmed, S. F., & Irtisam, N. (2021) · Robotics and Autonomous Systems · doi:10.1016/j.robot.2021.103902 · Cited by 199 · see citing works

Deep learning for drug repurposing: Methods, databases, and applications

Pan, X., Lin, X., Cao, D., Zeng, X., Yu, P. S., He, L., Nussinov, R., & Cheng, F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1597 · Cited by 193 · see citing works

Drug combination therapy for emerging viral diseases

Shyr, Z. A., Cheng, Y., Lo, D. C., & Zheng, W. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.05.008 · Cited by 191 · see citing works

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180 · see citing works

Tribulations and future opportunities for artificial intelligence in precision medicine

Carini, C., & Seyhan, A. A. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05067-0 · Cited by 175 · see citing works

Shaping the future of AI in healthcare through ethics and governance

Bouderhem, R. (2024) · Humanities and Social Sciences Communications · doi:10.1057/s41599-024-02894-w · Cited by 195 · see citing works

PharmKG: a dedicated knowledge graph benchmark for bomedical data mining

Zheng, S., Rao, J., Ying, S., Zhang, J., Xiao, X., Fang, E. F., Yang, Y., & Niu, Z. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa344 · Cited by 166 · see citing works

Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment

Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A. R., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L. E., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00850-3 · Cited by 160 · see citing works

Drug repurposing for COVID-19: Approaches, challenges and promising candidates

Ng, Y.-L., Salim, C. K., & Chu, J. (2021) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2021.107930 · Cited by 124 · see citing works

The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic

Piccialli, F., Cola, V. S. D., Giampaolo, F., & Cuomo, S. (2021) · Information Systems Frontiers · doi:10.1007/s10796-021-10131-x · Cited by 153 · see citing works

Translational precision medicine: an industry perspective

Hartl, D., Luca, V. D., Kostikova, A., Laramie, J. M., Kennedy, S., Ferrero, E., Siegel, R. W., Fink, M., Ahmed, S., Millholland, J. M., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02910-6 · Cited by 153 · see citing works

Crisis as opportunity, disruption and exposure: Exploring emergent responses to crisis through digital technology

Gkeredakis, M., Lifshitz-Assaf, H., & Barrett, M. (2021) · Information and Organization · doi:10.1016/j.infoandorg.2021.100344 · Cited by 173 · see citing works

Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layers

Bang, D., Lim, S., Lee, S., & Kim, S. (2023) · Nature Communications · doi:10.1038/s41467-023-39301-y · Cited by 131 · see citing works

Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor

Hashimoto, K. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01231-x · Cited by 118 · see citing works

Current Strategies of Antiviral Drug Discovery for COVID-19

Mei, M., & Tan, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.671263 · Cited by 110 · see citing works

Biomolecular modeling thrives in the age of technology

Tamar Schlick, A., & Portillo‐Ledesma, S. (2021) · Nature Computational Science · doi:10.1038/s43588-021-00060-9 · Cited by 110 · see citing works

Face mask detection using MobileNet and Global Pooling Block

Isunuri, B. V., Kakarla, J., & Prakash, S. (2020) · IEEE Conference on Information and Communication Technology (CICT) · doi:10.1109/cict51604.2020.9312083 · Cited by 108 · see citing works

Healthcare knowledge graph construction: A systematic review of the state-of-the-art, open issues, and opportunities

Abu-Salih, B., Al‐Qurishi, M., Alweshah, M., AL-Smadi, M., Alfayez, R., & Saadeh, H. (2023) · Journal Of Big Data · doi:10.1186/s40537-023-00774-9 · Cited by 121 · see citing works

Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery

Bagabir, S. A., Ibrahim, N. K., Bagabir, H. A., & Ateeq, R. H. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.01.011 · Cited by 106 · see citing works

The metaverse in current digital medicine

Sun, M., Xie, L., Liu, Y., Li, K., Jiang, B., Lu, Y., Yang, Y., Yu, H., Song, Y., Bai, C., et al. (2022) · Clinical eHealth · doi:10.1016/j.ceh.2022.07.002 · Cited by 104 · see citing works

Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19

Arora, G., Joshi, J., Mandal, R. S., Shrivastava, N., Virmani, R., & Sethi, T. (2021) · Pathogens · doi:10.3390/pathogens10081048 · Cited by 111 · see citing works

A heterogeneous network embedding framework for predicting similarity-based drug-target interactions

An, Q., & Yu, L. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab275 · Cited by 99 · see citing works

Rise of multiattribute decision‐making in combating COVID‐19: A systematic review of the state‐of‐the‐art literature

Alsalem, M. A., Mohammed, R. T., Albahri, O. S., Zaidan, A. A., Alamoodi, A. H., Dawood, K. A., Alnoor, A., Albahri, A. S., Zaidan, B. B., Aickelin, U., et al. (2021) · International Journal of Intelligent Systems · doi:10.1002/int.22699 · Cited by 94 · see citing works

A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19

Ahmed, F., Soomro, A. M., Salih, A. R. C., Samantasinghar, A., Asif, A., Kang, I. S., & Choi, K. H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113350 · Cited by 92 · see citing works

Transforming healthcare through a digital revolution: A review of digital healthcare technologies and solutions

Naik, N., Hameed, B. M. Z., Sooriyaperakasam, N., Vinayahalingam, S., Patil, V., Smriti, K., Saxena, J., Shah, M., Ibrahim, S., Singh, A., et al. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.919985 · Cited by 93 · see citing works

Viral outbreaks detection and surveillance using wastewater-based epidemiology, viral air sampling, and machine learning techniques: A comprehensive review and outlook

Abdeldayem, O. M., Dabbish, A. M., Habashy, M. M., Mostafa, M. K., Elhefnawy, M., Amin, L., Al-Sakkari, E. G., Ragab, A., & Rene, E. R. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149834 · Cited by 90 · see citing works

Blockchain, artificial intelligence, and healthcare: the tripod of future—a narrative review

Bathula, A., Gupta, S. K., Merugu, S., Saba, L., Khanna, N. N., Laird, J. R., Sanagala, S. S., Singh, R. K., Garg, D., Fouda, M. M., et al. (2024) · Artificial Intelligence Review · doi:10.1007/s10462-024-10873-5 · Cited by 100 · see citing works

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery

Zhou, Y., Fang, J., Bekris, L. M., Kim, Y. H., Pieper, A. A., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00760-w · Cited by 86 · see citing works

Graphene Oxide Nanosheets Interact and Interfere with SARS‐CoV‐2 Surface Proteins and Cell Receptors to Inhibit Infectivity

Ünal, M. A., Bayrakdar, F., Nazır, H., Beşbinar, Ö., Gürcan, C., Lozano, N., Arellano, L. M., Yalçın, S., Panatli, O., Çelik, D., et al. (2021) · Small · doi:10.1002/smll.202101483 · Cited by 82 · see citing works

Repurposing drugs for the management of COVID-19

Cusinato, J., Cau, Y., Calvani, A. M., & Mori, M. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1861248 · Cited by 79 · see citing works

Machine learning research towards combating COVID-19: Virus detection, spread prevention, and medical assistance

Shahid, O., Nasajpour, M., Pouriyeh, S., Parizi, R. M., Han, M., Valero, M., Li, F., Aledhari, M., & Sheng, Q. Z. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2021.103751 · Cited by 75 · see citing works

SAveRUNNER: an R-based tool for drug repurposing

Fiscon, G., & Paci, P. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04076-w · Cited by 74 · see citing works

The Promise of AI in Detection, Diagnosis, and Epidemiology for Combating COVID-19: Beyond the Hype

Abdulkareem, M., & Petersen, S. E. (2021) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.652669 · Cited by 78 · see citing works

Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China

Dong, J., Wu, H., Zhou, D., Li, K., Zhang, Y., Ji, H., Tong, Z., Lou, S., & Liu, Z. (2021) · Journal of Medical Systems · doi:10.1007/s10916-021-01757-0 · Cited by 74 · see citing works

Artificial intelligence and machine learning methods in predicting anti-cancer drug combination effects

Fan, K., Cheng, L., & Li, L. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab271 · Cited by 74 · see citing works

Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19

Manjunath, S. H., & Thimmulappa, R. K. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.09.009 · Cited by 73 · see citing works

Applications of Artificial Intelligence, Machine Learning, Big Data and the Internet of Things to the COVID-19 Pandemic: A Scientometric Review Using Text Mining

Rodríguez‐Rodríguez, I., Rodríguez, J., Shirvanizadeh, N., Ortíz, A., & Pardo-Quiles, D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168578 · Cited by 77 · see citing works

The machine learning life cycle and the cloud: implications for drug discovery

Spjuth, O., Frid, J., & Hellander, A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1932812 · Cited by 67 · see citing works

The Potential Applications of Artificial Intelligence in Drug Discovery and Development

Farghali, H., Kutinová Canová, N., & Arora, M. (2021) · Physiological Research · doi:10.33549/physiolres.934765 · Cited by 72 · see citing works

Artificial Intelligence in Drug Design: Algorithms, Applications, Challenges and Ethics

Arabi, A. A. (2021) · Future Drug Discovery · doi:10.4155/fdd-2020-0028 · Cited by 74 · see citing works

Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review

Tripathi, N., Goshisht, M. K., Sahu, S. K., & Arora, C. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10237-z · Cited by 74 · see citing works

TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow

Kalakoti, Y., Yadav, S., & Sundar, D. (2022) · ACS Omega · doi:10.1021/acsomega.1c05203 · Cited by 73 · see citing works

Drug Design and Disease Diagnosis: The Potential of Deep Learning Models in Biology

Sreeraman, S., Mayuri, K., Kushwah, R. B. S., Sundaram, V., Veluchamy, A., Anand, T., & Saravanan, K. M. (2023) · Current Bioinformatics · doi:10.2174/1574893618666230227105703 · Cited by 70 · see citing works

The Application of Artificial Intelligence in Health Care Resource Allocation Before and During the COVID-19 Pandemic: Scoping Review

Wu, H., Lu, X., & Wang, H. (2023) · JMIR AI · doi:10.2196/38397 · Cited by 69 · see citing works

Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches

Ahmed, F., Kang, I. S., Kim, K. H., Asif, A., Rahim, C. S. A., Samantasinghar, A., Memon, F. H., & Choi, K. H. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28693 · Cited by 75 · see citing works

The Role of Chatbots in Enhancing Customer Experience: Literature Review

Bakkouri, B. E., Raki, S., & Belgnaoui, L. T. (2022) · Procedia Computer Science · doi:10.1016/j.procs.2022.07.057 · Cited by 88 · see citing works

Transforming clinical virology with AI, machine learning and deep learning: a comprehensive review and outlook

Padhi, A., Agarwal, A., Saxena, S. K., & Katoch, C. D. S. (2023) · VirusDisease · doi:10.1007/s13337-023-00841-y · Cited by 67 · see citing works

Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges

Qi, X., Zhao, Y., Qi, Z., Hou, S., & Chen, J. (2024) · Molecules · doi:10.3390/molecules29040903 · Cited by 75 · see citing works

Application of Artificial Intelligence in COVID-19 Pandemic: Bibliometric Analysis

Islam, M. M., Poly, T. N., Alsinglawi, B. S., Lin, L., Chien, S.-C., Liu, J., & Jian, W. (2021) · Healthcare · doi:10.3390/healthcare9040441 · Cited by 66 · see citing works

Antisense Oligonucleotide-Based Therapy of Viral Infections

Tarn, W., Cheng, Y., Ko, S.-H., & Huang, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122015 · Cited by 64 · see citing works

Expert-Augmented computational drug repurposing identified baricitinib as a treatment for COVID-19

Smith, D. P., Oechsle, O., Rawling, M. J., Savory, E., Lacoste, A. M. B., & Richardson, P. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709856 · Cited by 62 · see citing works

Comprehensive Survey of Using Machine Learning in the COVID-19 Pandemic

El-Rashidy, N. M., Abdelrazek, S. M., Abuhmed, T., Amer, E., Ali, F., Hu, J. W., & El–Sappagh, S. (2021) · Diagnostics · doi:10.3390/diagnostics11071155 · Cited by 61 · see citing works

A Framework for Augmented Intelligence in Allergy and Immunology Practice and Research—A Work Group Report of the AAAAI Health Informatics, Technology, and Education Committee

Khoury, P., Srinivasan, R., Kakumanu, S., Ochoa, S., Keswani, A., Sparks, R., & Rider, N. L. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.01.047 · Cited by 64 · see citing works

Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer’s disease

Cheng, F., Wang, F., Tang, J., Zhou, Y., Fu, Z., Zhang, P., Haines, J. L., Leverenz, J. B., Gan, L., Hu, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101379 · Cited by 63 · see citing works

Development and application of therapeutic antibodies against COVID-19

Ning, L.-J., Abagna, H. B., Jiang, Q., Liu, S., & Huang, J. (2021) · International Journal on Biological Sciences · doi:10.7150/ijbs.59149 · Cited by 52 · see citing works

Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives

Vivekanandhan, K., Poornima, S., Barabadi, H., Arumugam, V., Raj, D. D. R. D. P., Manikandan, S., Subbaiya, R., Anand, K., Pandi, B., Chandrasekaran, B., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.604447 · Cited by 58 · see citing works

Social and Behavioral Determinants of Health in the Era of Artificial Intelligence with Electronic Health Records: A Scoping Review

Bompelli, A., Wang, Y., Wan, R., Singh, E., Zhou, Y., Xu, L., Oniani, D., Kshatriya, B. S. A., Balls-Berry, J. (. E., & Zhang, R. (2021) · Health Data Science · doi:10.34133/2021/9759016 · Cited by 58 · see citing works

Data-Driven Analytics Leveraging Artificial Intelligence in the Era of COVID-19: An Insightful Review of Recent Developments

Majeed, A., & Hwang, S. O. (2021) · Symmetry · doi:10.3390/sym14010016 · Cited by 62 · see citing works

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2

Prasad, K., & Kumar, V. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100042 · Cited by 58 · see citing works

Machine learning and network medicine approaches for drug repositioning for COVID-19

Santos, S. D. S., Torres, M., Galeano, D., Sánchez, M. D. M., Cernuzzi, L., & Paccanaro, A. (2021) · Patterns · doi:10.1016/j.patter.2021.100396 · Cited by 55 · see citing works

Exploring the Role of Artificial Intelligence in Smart Healthcare: A Capability and Function-Oriented Review

Abbas, S. R., Seol, H., Abbas, Z., & Lee, S. W. (2025) · Healthcare · doi:10.3390/healthcare13141642 · Cited by 55 · see citing works

Data science approaches to confronting the COVID-19 pandemic: a narrative review

Zhang, Q., Gao, J., Wu, J. T. K., Cao, Z., & Zeng, D. D. (2021) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2021.0127 · Cited by 52 · see citing works

Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network

Sun, X., Wang, B., Zhang, J., & Li, M. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3194891 · Cited by 53 · see citing works

COVID-19 Epidemic and Opening of the Schools: Artificial Intelligence-Based Long-Term Adaptive Policy Making to Control the Pandemic Diseases

Tutsoy, Ö. (2021) · IEEE Access · doi:10.1109/access.2021.3078080 · Cited by 53 · see citing works

Recent advances from computer-aided drug design to artificial intelligence drug design

Wang, K., Huang, Y., Wang, Y., You, Q., & Wang, L. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00522h · Cited by 54 · see citing works

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins

May, D. G., Martin‐Sancho, L., Anschau, V., Liu, S. N., Chrisopulos, R. J., Scott, K. L., Halfmann, C. T., Peña, R. D., Pratt, D. R., Campos, A. R., et al. (2022) · Viruses · doi:10.3390/v14030611 · Cited by 50 · see citing works

HGTDR: Advancing drug repurposing with heterogeneous graph transformers

Gharizadeh, A., Abbasi, K., Ghareyazi, A., Mofrad, M. R. K., & Rabiee, H. R. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae349 · Cited by 49 · see citing works

Efficient machine learning model for predicting drug-target interactions with case study for Covid-19

El-Behery, H., Attia, A.-F. A., El-Fishawy, N. A., & Torkey, H. (2021) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2021.107536 · Cited by 45 · see citing works

Artificial Intelligence in Accelerating Drug Discovery and Development

Tripathi, A., Misra, K., Dhanuka, R., & Singh, J. P. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220802151129 · Cited by 45 · see citing works

In silico investigation on the inhibitory effect of fungal secondary metabolites on RNA dependent RNA polymerase of SARS-CoV-II: A docking and molecular dynamic simulation study

Ebrahimi, K. S., Ansari, M., Moghaddam, M. S. H., Ebrahimi, Z., Salehi, Z., Shahlaei, M., & Moradi, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104613 · Cited by 45 · see citing works

Artificial intelligence for COVID-19: battling the pandemic with computational intelligence

Xu, Z., Su, C., Xiao, Y., & Wang, F. (2021) · Intelligent Medicine · doi:10.1016/j.imed.2021.09.001 · Cited by 48 · see citing works

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets

Cheng, K., Martin‐Sancho, L., Pal, L. R., Pu, Y., Riva, L., Yin, X., Sinha, S., Nair, N. U., Chanda, S. K., & Ruppin, E. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110260 · Cited by 45 · see citing works

Leveraging clinical data across healthcare institutions for continual learning of predictive risk models

Amrollahi, F., Shashikumar, S. P., Holder, A. L., & Nemati, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12497-7 · Cited by 43 · see citing works

AI-Driven Drug Discovery for Rare Diseases

Gangwal, A., & Lavecchia, A. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01966 · Cited by 47 · see citing works

Data science in unveiling COVID-19 pathogenesis and diagnosis: evolutionary origin to drug repurposing

Das, J. K., Tradigo, G., Veltri, P., Guzzi, P. H., & Roy, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa420 · Cited by 43 · see citing works

Combination therapies for COVID‐19: An overview of the clinical trials landscape

Akinbolade, S., Coughlan, D., Fairbairn, R., McConkey, G. A., Powell, H., Ogunbayo, O. J., & Craig, D. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15089 · Cited by 43 · see citing works

Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection

Ge, R., Shen, Z., Yin, J., Chen, W., Zhang, Q., An, Y., Tang, D., Satz, A. L., Su, W., & Kuai, L. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2022.01.001 · Cited by 43 · see citing works

Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues

Gatti, M., Turrini, E., Raschi, E., Sestili, P., & Fimognari, C. (2021) · Pharmaceuticals · doi:10.3390/ph14080738 · Cited by 42 · see citing works

Review of Oxygenation with Nanobubbles: Possible Treatment for Hypoxic COVID-19 Patients

Afshari, R., Akhavan, O., Hamblin, M. R., & Varma, R. S. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c01907 · Cited by 43 · see citing works

Modern machine‐learning for binding affinity estimation of protein–ligand complexes: Progress, opportunities, and challenges

Harren, T., Gutermuth, T., Grebner, C., Heßler, G., & Rarey, M. (2024) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1716 · Cited by 42 · see citing works

AI in Orthopedic Research: A Comprehensive Review

Mısır, A., & Yuce, A. (2025) · Journal of Orthopaedic Research® · doi:10.1002/jor.26109 · Cited by 45 · see citing works

Systems Biology in Cancer Diagnosis Integrating Omics Technologies and Artificial Intelligence to Support Physician Decision Making

Fawaz, A., Ferraresi, A., & Isidoro, C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111590 · Cited by 43 · see citing works

Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment

Vivarelli, S., Candido, S., Caruso, G., Falzone, L., & Libra, M. (2020) · Cancers · doi:10.3390/cancers12123636 · Cited by 41 · see citing works

Artificial Intelligence Applications for COVID-19 in Intensive Care and Emergency Settings: A Systematic Review

Chee, M. L., Ong, M. E. H., Siddiqui, F. J., Zhang, Z., Lim, S. L., Ho, A. F. W., & Liu, N. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094749 · Cited by 36 · see citing works

Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study

Nawrot-Hadzik, I., Żmudziński, M., Matkowski, A., Preißner, R., Kęsik-Brodacka, M., Hadzik, J., Drąg, M., & Abel, R. (2021) · Pharmaceuticals · doi:10.3390/ph14080742 · Cited by 40 · see citing works

A REVIEW OF ARTIFICIAL INTELLIGENCE IN TREATMENT OF COVID-19

Gandla, K., Teja, K., Babu, P. V., Sagapola, R., & Sudhakar, P. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s01.31 · Cited by 13 · see citing works

Topical Repute on Artificial Intelligence-Based Approaches in COVID-19 Supervision

Basu, S., & Shafi, J. (2022) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-6684-3791-9.ch008

Application of Artificial Intelligence in COVID-19 drug repurposing

Mohanty, S., Rashid, M. H. A., Mridul, M., Mohanty, C., & Swayamsiddha, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.068 · Cited by 207 · see citing works

AI vital in finding new targets for existing drugs

Sivaraman, D., & Pradeep, P. S. (2021) · Nature India · doi:10.1038/nindia.2021.11

Development and repurposing of drugs against COVID-19 using artificial intelligence

Mitra, A., & Bhattacharya, A. (2023) · De Gruyter eBooks · doi:10.1515/9783110767681-007 · Cited by 3 · see citing works